-80.9%
FIG vs MRNA
+334.5%
-415.5%
-86.2%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for all.
| Period | Portfolio | MRNA | Excess | Alpha |
|---|---|---|---|---|
| 1D | -3.3% | -3.4% | +0.1% | -3.1% |
| 7D | -14.5% | -10.1% | -4.4% | -14.1% |
| 30D | -13.3% | +126.7% | -140.0% | -19.8% |
| 3M | +7.4% | +184.1% | -176.7% | -4.0% |
| 6M | -27.8% | +143.3% | -171.1% | -33.9% |
| YTD | -41.1% | +359.9% | -401.0% | -53.0% |
| 1Y | -58.7% | +454.2% | -512.9% | -68.4% |
| All | -80.9% | +334.5% | -415.5% | -86.2% |
Cumulative growth
Daily Returns
Daily percentage return beside MRNA.
Daily Out/Under-Performance
Portfolio return minus MRNA return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × MRNA return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over all: compounded portfolio wealth divided by compounded MRNA wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
all analysis · Full analysis span regression · 6 months rolling